Birth outcomes of cases with different congenital heart defects - a population-based study
-
2015-04-18 https://doi.org/10.14419/ijh.v3i1.4406 -
Congenital Heart Defects, Low Birthweight, Population-Based Study, Preterm Birth, Small for Gestational Age. -
Abstract
Background: In general, previous epidemiological studies evaluated congenital heart defects (CHDs) together. The aim of the present study was to identify possible etiological factors of different CHD-entities, because the underlying causes are unclear in the vast majority of patients.
Objectives: Different CHD-entities as homogeneously as possible with confirmed diagnoses were analyzed in the population-based large dataset of the Hungarian Case-Control Surveillance of Congenital Abnormalities.
Methods: 3,750 live-born singleton CHD-patients were analyzed according to birth outcomes, i.e. gestational age at delivery and birth weight, the rate of preterm birth, low birthweight and small for gestational age.
Results: The major findings of the study showed that cases with different CHD-entities had shorter gestational age at delivery and lower mean birth weight, and these variables associated with a higher rate of preterm birth and particularly with a much higher rate of low birthweight and small for gestational age. This study showed the importance of sex in the birth outcomes of some CHD-entities. The question is why several CHD-entities manifested more frequently in newborns with intrauterine growth restriction because fetal heart has a passive role before birth without pulmonary circulation.
Conclusions: The birth outcomes of cases indicate the effect of CHDs for fetal development. In addition maternal confounders have to consider. Finally, CHDs and intrauterine growth restriction as two developmental errors may have a common route, thus fetal growth and birthweight associated gene polymorphisms may have a role in the origin of CHDs.
-
References
[1] Hoffman JI, Kaplan S & Liberthson RR (2004) Prevalence of congenital heart disease. American Heart Journal 147, 425-439. http://dx.doi.org/10.1016/j.ahj.2003.05.003.
[2] Dolk H, Loane M & Garne E; European Surveillance of ongenital Anomalies (EUROCAT) Working Group (2011) Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation 123, 841-849. http://dx.doi.org/10.1161/CIRCULATIONAHA.110.958405.
[3] Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT & Correa A (2008) Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. The Journal of Pediatrics 153, 807-813. http://dx.doi.org/10.1016/j.jpeds.2008.05.059.
[4] Czeizel A, Kamarás J, Balogh O & Szentpéteri J (1972) Incidence of congenital heart defects in Budapest. Acta Paediatrica Academiae Scientiarum Hungaricae 13, 191-202.
[5] Mészáros M, Nagy A & Czeizel A (1975) Incidence of congenital heart disease in Hungary. Human Heredity 25, 513-519. http://dx.doi.org/10.1159/000152769.
[6] Fulton DR (2008) congenital heart diseases in children and adolescent. In Hurst's the Heart (Fuster V, Walsh A, O'Rourke RA, Poole-Wilson P eds.), McGraw Hill Medical, New York, pp. 1855-1921.
[7] Cleves MA, Ghaffar S, Zhao W, Mosley BS & Hobbs CA (2003) First-year survival of infants born with congenital heart defects in Arkansas (1993-1998): a survival analysis using registry data. Birth Defects Research. Part A, Clinical and Molecular Teratology 67, 662-668. http://dx.doi.org/10.1002/bdra.10119.
[8] Pierpont ME, Basson CT, Benson DW Jr, Gelb BD, Giglia TM, Goldmuntz E, McGee G, Sable CA, Srivastava D & Webb CL; American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young (2007) Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115, 3015-3038. http://dx.doi.org/10.1161/CIRCULATIONAHA.106.183056.
[9] Jenkins KJ, Correa A, Feinstein JA, Botto L, Britt AE, Daniels SR, Elixson M, Warnes CA & Webb CL; American Heart Association Council on Cardiovascular Disease in the Young (2007) Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115, 2995-3014. http://dx.doi.org/10.1161/CIRCULATIONAHA.106.183216.
[10] Czeizel AE, Rockenbauer M, Siffel Cs & Varga E (2001) Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-1996. Teratology 63, 176-185. http://dx.doi.org/10.1002/tera.1032.
[11] Botto LD, Lin AE, Riehle-Colarusso T, and Malik S & Correa a (2007) Seeking cause: Classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Research. Part A, Clinical and Molecular Teratology 79, 714-727. http://dx.doi.org/10.1002/bdra.20403.
[12] Ferencz C, Loffredo CA, Rubin JD & Magee CA (1993) Epidemiology of Congenital Heart Diseases. The Baltimore-Washington Infant Study: 1981-1989. Future Publ Co., Mount Kisco, New York.
[13] Ferencz C, Loffredo CA, Correa-Villasenor A & Wilson PD (1997) Genetic and Environmental Risk Factors of Major Cardiovascular Malformations: The Baltimore-Washington Infant Study: 1981-1989. Future Publ Co., Armonk, New York.
[14] Czeizel AE (1997) the first 25 years of the Hungarian congenital abnormality registry. Teratology 55, 299-305. http://dx.doi.org/10.1002/(SICI)1096-9926(199705)55:5<299::AID-TERA1>3.0.CO;2-V.
[15] Czeizel AE, Métneki J & Béres J (2014) 50 years of the Hungarian Congenital Abnormality Registry. Congenital Anomalies (Kyoto) 54, 22-29. http://dx.doi.org/10.1111/cga.12025.
[16] Czeizel AE, Intődy Z & Modell B (1993) what proportion of congenital abnormalities can be prevented? British Medical Journal 306, 499-503. http://dx.doi.org/10.1136/bmj.306.6876.499.
[17] Czeizel AE, Petik D & Vargha P (2003) Validation studies of drug exposures in pregnant women. Pharmacoepidemiology and Drug Safety 12, 409-416. http://dx.doi.org/10.1002/pds.766.
[18] Czeizel AE & Vargha P (2004) Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology 191, 790-794. http://dx.doi.org/10.1016/j.ajog.2004.02.018.
[19] Ãcs N, Bánhidy F, Puho E & Czeizel AE (2005) maternal influenza during pregnancy and risk of congenital abnormalities in offspring. Birth Defects Research. Part A, Clinical and Molecular Teratology 73, 989-996. http://dx.doi.org/10.1002/bdra.20195.
[20] Fyler DC (1992) Atrial septal defect secundum. In Nadas' Pediatric Cardiology (Fyler DC ed.), Mosby Year Book, Boston, pp. 513-524.
[21] Vereczkey A, Kosa Z, Csáky-Szunyogh M, Urbán R & Czeizel AE (2013) Birth outcomes of cases with isolated atrial septal defect type II - a population-based case-control study. Acta Obstetricia ET Gynecologica Scandinavica 92, 824-829. http://dx.doi.org/10.1111/aogs.12062.
[22] Rosenthal GL (1996) Patterns of prenatal growth among infants with cardiovascular malformations: possible fetal hemodynamic effects. American Journal of Epidemiology 143, 505-513. http://dx.doi.org/10.1093/oxfordjournals.aje.a008771.
[23] Vereczkey A, Kosa Zs, Csáky-Szunyogh M, Urbán R & Czeizel AE (2012) Ventricular septal defect in function of maternal sociodemographic aspects. Central European Journal of Medicine 7, 511-522. http://dx.doi.org/10.2478/s11536-012-0024-x.
[24] Czeizel AE, Petik D & Puho E (2003) Smoking and alcohol drinking during pregnancy. The reliability of retrospective maternal self-reported information. Central European Journal of Public Health 12, 179-183.
[25] Ãcs N, Bánhidy F & Czeizel AE (2010) Congenital Abnormalities and Preterm Birth Related to Maternal Illnesses During Pregnancy. Springer Verlag, Dordrecht, Heidelberg, London, New York. http://dx.doi.org/10.1007/978-90-481-8620-4.
[26] Freathy RM, Mook-Kanamori DO, Sovio U, Prokopenko I, Timpson NJ, Berry DJ, Warrington NM, Widen E, Hottenga JJ, Kaakinen M, Lange LA, Bradfield JP, Kerkhof M, Marsh JA, Mägi R, Chen CM, Lyon HN, Kirin M, Adair LS, Aulchenko YS, Bennett AJ, Borja JB, Bouatia-Naji N, Charoen P, Coin LJ, Cousminer DL, de Geus EJ, Deloukas P, Elliott P, Evans DM, Froguel P; Genetic Investigation of ANthropometric Traits (GIANT) Consortium, Glaser B, Groves CJ, Hartikainen AL, Hassanali N, Hirschhorn JN, Hofman A, Holly JM, Hyppönen E, Kanoni S, Knight BA, Laitinen J, Lindgren CM; Meta-Analyses of Glucose and Insulin-related traits Consortium, McArdle WL, O'Reilly PF, Pennell CE, Postma DS, Pouta A, Ramasamy A, Rayner NW, Ring SM, Rivadeneira F, Shields BM, Strachan DP, Surakka I, Taanila A, Tiesler C, Uitterlinden AG, van Duijn CM; Wellcome Trust Case Control Consortium, Wijga AH, Willemsen G, Zhang H, Zhao J, Wilson JF, Steegers EA, Hattersley AT, Eriksson JG, Peltonen L, Mohlke KL, Grant SF, Hakonarson H, Koppelman GH, Dedoussis GV, Heinrich J, Gillman MW, Palmer LJ, Frayling TM, Boomsma DI, Davey Smith G, Power C, Jaddoe VW, Jarvelin MR; Early Growth Genetics (EGG) Consortium & McCarthy MI (2010) Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight. Nature Genetics 42, 430-435. http://dx.doi.org/10.1038/ng.567.
-
Downloads
-
How to Cite
Vereczkey, A., Gerencsér, B., Czeizel, A. E., & Szabó, I. (2015). Birth outcomes of cases with different congenital heart defects - a population-based study. International Journal of Health, 3(1), 7-13. https://doi.org/10.14419/ijh.v3i1.4406Received date: 2015-02-23
Accepted date: 2015-03-24
Published date: 2015-04-18